A case of Lynch syndrome diagnosed by microsatellite instability test performed as universal screening

A 56-year-old male was admitted for surgery for transverse colon cancer. The patient had no paternal family history because his father died in an accident in his 40s. The patient underwent right hemi-colectomy. The histological diagnosis was moderately differentiated tubular adenocarcinoma (tub2>...

Full description

Saved in:
Bibliographic Details
Published inJOURNAL OF FAMILIAL TUMORS Vol. 19; no. 2; pp. 72 - 76
Main Authors Sekine, Shigeki, Kobatake, Takaya, Kobayashi, Naruyuki, Matsuyama, Yumi, Sugano, Kokichi, Hori, Shinichiro, Ochiai, Ryoji, Okamura, Miki, Teramoto, Norihiro, Ohsumi, Shozo, Kaneko, Keika
Format Journal Article
LanguageJapanese
Published The Japanese Society for Hereditary Tumors 2019
一般社団法人日本遺伝性腫瘍学会
Subjects
Online AccessGet full text
ISSN1346-1052
2189-6674
DOI10.18976/jsft.19.2_72

Cover

Abstract A 56-year-old male was admitted for surgery for transverse colon cancer. The patient had no paternal family history because his father died in an accident in his 40s. The patient underwent right hemi-colectomy. The histological diagnosis was moderately differentiated tubular adenocarcinoma (tub2>por1), pT2pN0cM0 pStage I (Japanese Classification of Colorectal Carcinoma, 8th edition). Microsatellite instability (MSI) test demonstrated the tumor to be MSI-High. Genetic testing revealed a pathogenic mutation in MSH6 and Lynch syndrome was diagnosed. Although the patient did not meet the Amsterdam Criteria II or the revised Bethesda guidelines, universal screening by MSI test led to the diagnosis of Lynch syndrome. Universal screening is useful to identify potential Lynch syndrome patients.
AbstractList A 56-year-old male was admitted for surgery for transverse colon cancer. The patient had no paternal family history because his father died in an accident in his 40s. The patient underwent right hemi-colectomy. The histological diagnosis was moderately differentiated tubular adenocarcinoma (tub2>por1), pT2pN0cM0 pStage I (Japanese Classification of Colorectal Carcinoma, 8th edition). Microsatellite instability (MSI) test demonstrated the tumor to be MSI-High. Genetic testing revealed a pathogenic mutation in MSH6 and Lynch syndrome was diagnosed. Although the patient did not meet the Amsterdam Criteria II or the revised Bethesda guidelines, universal screening by MSI test led to the diagnosis of Lynch syndrome. Universal screening is useful to identify potential Lynch syndrome patients. MSI(microsatellite instability)検査によるユニバーサルスクリーニングを契機に発見された,リンチ症候群の1例を経験したので報告する.患者は56歳,男性.便潜血陽性のため施行された下部内視鏡検査で横行結腸癌と診断された.家族歴は,父親が40歳代で事故死しており,父方の情報が全く得られなかった.母方の血縁者に癌罹患者は認められなかった.結腸右半切除術を施行し,病理学的検査結果は中分化管状腺癌,pT2pN0cM0 pStageⅠであった.ユニバーサルスクリーニングとして行ったMSI検査の結果は,MSI-H(MSI-High)であった.遺伝学的検査でMSH6に病的変異を認め,リンチ症候群と診断された.術後5年経過し,無再発生存中である.本症例は,アムステルダム基準Ⅱと改訂ベセスダガイドラインを明確に満たさなかったが,MSI検査から確定診断につなげることができた.ユニバーサルスクリーニングは,両基準非該当症例におけるリンチ症候群の拾い上げに有用と考えられた.
A 56-year-old male was admitted for surgery for transverse colon cancer. The patient had no paternal family history because his father died in an accident in his 40s. The patient underwent right hemi-colectomy. The histological diagnosis was moderately differentiated tubular adenocarcinoma (tub2>por1), pT2pN0cM0 pStage I (Japanese Classification of Colorectal Carcinoma, 8th edition). Microsatellite instability (MSI) test demonstrated the tumor to be MSI-High. Genetic testing revealed a pathogenic mutation in MSH6 and Lynch syndrome was diagnosed. Although the patient did not meet the Amsterdam Criteria II or the revised Bethesda guidelines, universal screening by MSI test led to the diagnosis of Lynch syndrome. Universal screening is useful to identify potential Lynch syndrome patients.
Author Ohsumi, Shozo
Hori, Shinichiro
Sekine, Shigeki
Kobatake, Takaya
Matsuyama, Yumi
Teramoto, Norihiro
Ochiai, Ryoji
Kaneko, Keika
Okamura, Miki
Sugano, Kokichi
Kobayashi, Naruyuki
Author_FL 堀 伸一郎
寺本 典弘
Kobayashi Naruyuki
落合 亮二
Kobatake Takaya
関根 茂樹
金子 景香
菅野 康吉
岡村 弥妃
松山 裕美
大住 省三
Author_FL_xml – sequence: 1
  fullname: Kobayashi Naruyuki
– sequence: 2
  fullname: 落合 亮二
– sequence: 3
  fullname: Kobatake Takaya
– sequence: 4
  fullname: 金子 景香
– sequence: 5
  fullname: 松山 裕美
– sequence: 6
  fullname: 岡村 弥妃
– sequence: 7
  fullname: 堀 伸一郎
– sequence: 8
  fullname: 寺本 典弘
– sequence: 9
  fullname: 関根 茂樹
– sequence: 10
  fullname: 菅野 康吉
– sequence: 11
  fullname: 大住 省三
Author_xml – sequence: 1
  fullname: Sekine, Shigeki
  organization: Department of Genetic Medicine and Service, National Cancer Center Hospital
– sequence: 1
  fullname: Kobatake, Takaya
  organization: Department of Gastroenterological Surgery, National Hospital Organization, Shikoku Cancer Center
– sequence: 1
  fullname: Kobayashi, Naruyuki
  organization: Department of familial Cancer, National Hospital Organization, Shikoku Cancer Center
– sequence: 1
  fullname: Matsuyama, Yumi
  organization: Department of familial Cancer, National Hospital Organization, Shikoku Cancer Center
– sequence: 1
  fullname: Sugano, Kokichi
  organization: Oncogene Research Unit/ Cancer Prevention Unit, Tochigi Cancer Center Research Institute
– sequence: 1
  fullname: Hori, Shinichiro
  organization: Department of Gastroenterology, National Hospital Organization, Shikoku Cancer Center
– sequence: 1
  fullname: Ochiai, Ryoji
  organization: Department of Gastroenterological Surgery, National Hospital Organization, Shikoku Cancer Center
– sequence: 1
  fullname: Okamura, Miki
  organization: Department of familial Cancer, National Hospital Organization, Shikoku Cancer Center
– sequence: 1
  fullname: Teramoto, Norihiro
  organization: Department of Pathology, National Hospital Organization, Shikoku Cancer Center
– sequence: 1
  fullname: Ohsumi, Shozo
  organization: Department of Breast Oncology, National Hospital Organization, Shikoku Cancer Center
– sequence: 1
  fullname: Kaneko, Keika
  organization: Department of familial Cancer, National Hospital Organization, Shikoku Cancer Center
BackLink https://cir.nii.ac.jp/crid/1390565134831930880$$DView record in CiNii
BookMark eNo9kL1rwzAQxUVJoWmasbuGrk71YVvS0CGEfkGgS3Zxlk-JgiMHyS34v69DSpd3d48fB-_dk1nsIxLyyNmKa6Pq52P2w4qblbBK3JC5mNyirlU5I3Muy7rgrBJ3ZJlzaBhjWnGjzJz4NXWQkfaebsfoDjSPsU39CWkbYB_7jC1tRnoKLvUZBuy6MCANMQ_QhGkf6YB5oGdMvk-nCYZMv2P4wZSho9klxBji_oHceugyLv_mguzeXnebj2L79f65WW-Lo5asMG0D3mmn0QjnpPGAXjTGVB6aqhKlKzUwVKVXpgYpjGzUdIJ0TrhKyEouyNP1bQzBunBRLg2r6mqqQEtuJNOaTdjLFTtOMfZozymcII0W0hBch_ZSpeXGioso8e-7AySLUf4C5WFyOQ
ContentType Journal Article
Copyright 2019 The Japanese Society for Familial Tumors
Copyright_xml – notice: 2019 The Japanese Society for Familial Tumors
DBID RYH
DOI 10.18976/jsft.19.2_72
DatabaseName CiNii Complete
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate MSI検査によるユニバーサルスクリーニングが有用であったリンチ症候群の1例
DocumentTitle_FL MSI検査によるユニバーサルスクリーニングが有用であったリンチ症候群の1例
EISSN 2189-6674
EndPage 76
ExternalDocumentID 130007803647
article_jsft_19_2_19_72_article_char_en
GroupedDBID ABJNI
ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
MOJWN
RJT
RYH
ID FETCH-LOGICAL-j830-9dbafc8c8e92cc39faef2b995fab5524c48a0e74f796a3293b70e7a3cc2c52353
ISSN 1346-1052
IngestDate Thu Jun 26 22:01:48 EDT 2025
Wed Sep 03 06:29:09 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 2
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j830-9dbafc8c8e92cc39faef2b995fab5524c48a0e74f796a3293b70e7a3cc2c52353
OpenAccessLink https://www.jstage.jst.go.jp/article/jsft/19/2/19_72/_article/-char/en
PageCount 5
ParticipantIDs nii_cinii_1390565134831930880
jstage_primary_article_jsft_19_2_19_72_article_char_en
PublicationCentury 2000
PublicationDate 2019
PublicationDateYYYYMMDD 2019-01-01
PublicationDate_xml – year: 2019
  text: 2019
PublicationDecade 2010
PublicationTitle JOURNAL OF FAMILIAL TUMORS
PublicationTitleAlternate JOURNAL OF FAMILIAL TUMORS
PublicationTitle_FL 家族性腫瘍
JOURNAL OF FAMILIAL TUMORS
PublicationYear 2019
Publisher The Japanese Society for Hereditary Tumors
一般社団法人日本遺伝性腫瘍学会
Publisher_xml – name: The Japanese Society for Hereditary Tumors
– name: 一般社団法人日本遺伝性腫瘍学会
References 1)Lynch HT, de la Chapelle A: Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 1999; 36: 801–818
8)大腸癌研究会:遺伝性大腸癌診療ガイドライン2016年版.東京:金原出版,2016
6)Vasen HF: Clinical diagnosis and management of hereditary colorectal cancer syndromes. J Clin Oncol 2000; 18: 81S–92S
12)Sargent DJ, Marsoni S, Monges G, et al: Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol; 2010: 3219–3226
13)Brahmer JR, Drake CG, Wollner I, et al: Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol 2010; 28: 3167–3175
5)大腸癌研究会:大腸癌取扱い規約第8版.東京:金原出版,2013
10)NCCN-National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines). 2017. Genetic/familial high- risk assessment: colorectal. Version 3. https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf (2018.4.21)
11)Ribic CM, Sargent DJ, Moore MJ, et al: Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003; 349: 247–257
7)Umar A, Boland CR, Terdiman JP, et al: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch Syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96: 261–268
2)De la Chapella A: The incidence of Lynch syndrome. Fam Cancer 2005; 4: 233–237
3)Vasen HF, Blanco I, Aktan-Collan K, et al.: Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 2013; 62: 812–823
9)Canard G, Lefevre JH, Colas C, et al.: Screening for Lynch syndrome in colorectal cancer: Are we doing enough? Ann Surg Oncol 2012; 19: 809–816
15)Le DT, Uram JN, Wang H, et al: PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015; 25: 2509–2520
4)Hampel H, Frankel WL, Martin E, et al.: Screening for the Lynch syndrome (Hereditary Nonpolyposis Colorectal Cancer). N Engl J Med 2005; 352: 1851–1860
14)Lipson EJ, Sharfman WH, Drake CG, et al: Durable cancer regression off-treatment and effective re-induction therapy with an anti-PD-1 antibody. Clin cancer Res. 2013; 19: 462–468
References_xml – reference: 10)NCCN-National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines). 2017. Genetic/familial high- risk assessment: colorectal. Version 3. https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf (2018.4.21)
– reference: 12)Sargent DJ, Marsoni S, Monges G, et al: Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol; 2010: 3219–3226
– reference: 6)Vasen HF: Clinical diagnosis and management of hereditary colorectal cancer syndromes. J Clin Oncol 2000; 18: 81S–92S
– reference: 15)Le DT, Uram JN, Wang H, et al: PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015; 25: 2509–2520
– reference: 7)Umar A, Boland CR, Terdiman JP, et al: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch Syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96: 261–268
– reference: 5)大腸癌研究会:大腸癌取扱い規約第8版.東京:金原出版,2013
– reference: 1)Lynch HT, de la Chapelle A: Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 1999; 36: 801–818
– reference: 9)Canard G, Lefevre JH, Colas C, et al.: Screening for Lynch syndrome in colorectal cancer: Are we doing enough? Ann Surg Oncol 2012; 19: 809–816
– reference: 8)大腸癌研究会:遺伝性大腸癌診療ガイドライン2016年版.東京:金原出版,2016
– reference: 13)Brahmer JR, Drake CG, Wollner I, et al: Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol 2010; 28: 3167–3175
– reference: 2)De la Chapella A: The incidence of Lynch syndrome. Fam Cancer 2005; 4: 233–237
– reference: 3)Vasen HF, Blanco I, Aktan-Collan K, et al.: Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 2013; 62: 812–823
– reference: 14)Lipson EJ, Sharfman WH, Drake CG, et al: Durable cancer regression off-treatment and effective re-induction therapy with an anti-PD-1 antibody. Clin cancer Res. 2013; 19: 462–468
– reference: 4)Hampel H, Frankel WL, Martin E, et al.: Screening for the Lynch syndrome (Hereditary Nonpolyposis Colorectal Cancer). N Engl J Med 2005; 352: 1851–1860
– reference: 11)Ribic CM, Sargent DJ, Moore MJ, et al: Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003; 349: 247–257
SSID ssib000871979
ssib005902177
ssj0003306424
ssib044750618
Score 2.1683304
Snippet A 56-year-old male was admitted for surgery for transverse colon cancer. The patient had no paternal family history because his father died in an accident in...
SourceID nii
jstage
SourceType Publisher
StartPage 72
SubjectTerms Lynch syndrome, universal screening, microsatellite instability
リンチ症候群,ユニバーサルスクリーニング,MSI
Title A case of Lynch syndrome diagnosed by microsatellite instability test performed as universal screening
URI https://www.jstage.jst.go.jp/article/jsft/19/2/19_72/_article/-char/en
https://cir.nii.ac.jp/crid/1390565134831930880
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX JOURNAL OF FAMILIAL TUMORS, 2019, Vol.19(2), pp.72-76
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2189-6674
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0003306424
  issn: 1346-1052
  databaseCode: KQ8
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2189-6674
  dateEnd: 20191231
  omitProxy: true
  ssIdentifier: ssib044750618
  issn: 1346-1052
  databaseCode: M~E
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwEI-28cILAgFiwJAf8FOVkjq243t0u0wT40OgIe0tcpxEtBMtou1D-eu5c9KQiYkvqbJcx-c4vpzv58v5HEUvPehJrVUdV6BkLH1SxaWu6riEKmk8NL4WtDn57Tt9_km-vlJXB4fJwGtpuynH_vut-0r-h6tYhnylXbL_wNm-USzAPPIXU-Qwpn_FYzvyrrXFv9kt_ec-_ABZVMmBrkWXX8jnbu1C6M0NxQhBQBhcYhF4ok6gyMWEXLGyW4-2raNG2CpJLjl7zdbhV54rbnM-1TzXHDJuzihjEm4znhtu8OqU5xkHzPe-xEQ0Tbq6kCPdKFAZDglR2Qk3vbH2PTlfz0cfd6vF_JYGsGm8RzIKdJYb4LnkU-DQeyhfuGV9vRpd1PNrN7RpDObMQGOo29RnbGhGDVsszOlWMOU2pR5OU7obVbb0ax_ZqpCZBSpAJB4uYZ0Zh9PfjEYYulNu9b6yHSiEVGpUVW2U3XEdyhAVQax1e7pQr0VgIC1ioBIyMQAX7Vk3v6gtg6CQ9NYaK05gLIo90Y1I4PTlEREdfTnODqM7gixQ5IbwYQioswkMvrtScJ7Jz53GFN0RAZzprZBpWIC2Jz93D9oFoqUuvRp2CCHaAt9PikRxuJzPByjs8n50r1s-MdvKwoPoYOEeRo1lJAds1bAgB2wvB6yXA1bu2E05YAM5YCQHrJcD5taslwPWy8Gj6PIsv5ydx935IfHCpEkMVekab7ypQXifQuPqRpQAqnGlUkJ6aVxSZ7LJQLsUYW-Z4V-Xei-8EqlKH0dHy9WyfhKxyklfSe2bBNWXdFWpKpCZFyA9JKUqjyPdjk3xtY0RU3RzQkEjWEygEJRkoi-nPZU4hR1HJziWhZ9TiosxXI4o5IRBxZii_k-e_uH6s-guyU9rE3weHW2-besTRMmb8kV4MX4ADvibzQ
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+case+of+Lynch+syndrome+diagnosed+by+microsatellite+instability+test+performed+as+universal+screening&rft.jtitle=%E5%AE%B6%E6%97%8F%E6%80%A7%E8%85%AB%E7%98%8D&rft.au=%E5%B0%8F%E6%9E%97+%E6%88%90%E8%A1%8C&rft.au=Ochiai+Ryoji&rft.au=%E5%B0%8F%E7%95%A0+%E8%AA%89%E4%B9%9F&rft.au=Kaneko+Keika&rft.date=2019&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA%E6%97%A5%E6%9C%AC%E9%81%BA%E4%BC%9D%E6%80%A7%E8%85%AB%E7%98%8D%E5%AD%A6%E4%BC%9A&rft.issn=1346-1052&rft.eissn=2189-6674&rft.volume=19&rft.issue=2&rft.spage=72&rft.epage=76&rft_id=info:doi/10.18976%2Fjsft.19.2_72&rft.externalDocID=130007803647
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1346-1052&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1346-1052&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1346-1052&client=summon